Open Letter: Community Statement on Accelerating Access to Lenacapavir by Gilead

We are sharing a statement from a community and civil society leaders, advocates and activists meeting on long-acting drugs for the prevention and treatment of HIV which took place in Nairobi in April 2023.
In this statement, the community demands rapid action from Gilead to make Lenacapavir accessible in low and middle-income countries without further delay!

See the statement below:

Published: July 18, 2023